These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 18928998

  • 1. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.
    Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R.
    Am J Obstet Gynecol; 2008 Oct; 199(4):435.e1-7. PubMed ID: 18928998
    [Abstract] [Full Text] [Related]

  • 2. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
    Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A.
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
    [Abstract] [Full Text] [Related]

  • 3. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
    Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR.
    Arzneimittelforschung; 2010 Dec; 60(6a):386-98. PubMed ID: 20648930
    [Abstract] [Full Text] [Related]

  • 5. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
    Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C.
    Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
    [Abstract] [Full Text] [Related]

  • 6. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
    Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D.
    J Perinat Med; 2012 May 13; 40(5):469-74. PubMed ID: 22945271
    [Abstract] [Full Text] [Related]

  • 7. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N, Russell R.
    BJOG; 2006 Nov 13; 113(11):1248-52. PubMed ID: 17004982
    [Abstract] [Full Text] [Related]

  • 8. Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate to severe postpartum anaemia in Nigerian women (IVON-PP): protocol for an open-label randomised controlled type 1 hybrid effectiveness-implementation trial.
    Afolabi BB, Adaramoye VO, Adeyemo TA, Balogun M, Mitchell EJ, Walker K, Akinajo OR, Abioye IA, Banke-Thomas A, Babah OA, Chieme CF, Oshodi Y, Quao R, Eboreime EA, Ogunsola F.
    BMJ Open; 2024 Aug 17; 14(8):e086553. PubMed ID: 39153791
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
    Pfenniger A, Schuller C, Christoph P, Surbek D.
    J Perinat Med; 2012 Apr 02; 40(4):397-402. PubMed ID: 22752771
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia.
    Breymann C, Gliga F, Bejenariu C, Strizhova N.
    Int J Gynaecol Obstet; 2008 Apr 02; 101(1):67-73. PubMed ID: 18234203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J.
    Clin Ther; 2007 Aug 02; 29(8):1682-91. PubMed ID: 17919549
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.
    Am J Gastroenterol; 2005 Nov 02; 100(11):2503-9. PubMed ID: 16279906
    [Abstract] [Full Text] [Related]

  • 19. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P, Rumyantsev V.
    Arzneimittelforschung; 2010 Nov 02; 60(6a):373-85. PubMed ID: 20648929
    [Abstract] [Full Text] [Related]

  • 20. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
    Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, Ball MJ, Seaton D, Brain T, Rasko JE.
    J Intern Med; 2010 Sep 02; 268(3):286-95. PubMed ID: 20546462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.